Announced Tue, 16 Jun · 14:01 IST
AstraZeneca Pharma India appoints Director - Corporate Affairs
Management Changes View source PDF
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.5%1-day move
₹8400.00
prior close
₹8442.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0+0.0+0.0+0.9+1.5+1.4+0.7+2.1+1.0+0.5-3.0-3.1——
Up moveDown movePending
AI summary
AstraZeneca Pharma India has appointed Mr. Praveen K Mittal as Director - Corporate Affairs, effective July 6, 2026. The Board approved the appointment based on the Nomination and Remuneration Committee's recommendation. Mr. Mittal brings nearly 30 years of experience in corporate affairs and public policy. He currently heads the Export Promotion Council for Medical Devices and previously spent 18+ years at FICCI in healthcare policy leadership.
Likely market impact
Routine senior management hire to lead corporate affairs. Strengthens government relations and policy advocacy. Limited immediate stock impact expected.